IMO-2055
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for IMO-2055, covering 2013-10-22 to 2018-06-12. Get the full timeline:
Most recent: Clinical Trial Update: Study of IMO-2055 in Metastatic or Locally Recurrent Clear Cell Renal Carcinoma [Phase 2]